Biomarkers in immune checkpoint inhibition therapy for cancer patients: what is the role of lymphocyte subsets and PD1/PD-L1?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2396-832X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Biomarkers in immune checkpoint inhibition therapy for cancer patients: what is the role of lymphocyte subsets and PD1/PD-L1? ; volume:4 ; number:1 ; day:7 ; month:2 ; year:2019 ; pages:1-13 ; date:12.2019
Translational medicine communications ; 4, Heft 1 (7.2.2019), 1-13, 12.2019
- Creator
-
Singh, Puneet
Souza, Paul de
Scott, Kieran F.
Hall, Bruce M.
Verma, Nirupama D.
Becker, Therese M.
Toh, James W. T.
Sajinovic, Mila
Spring, Kevin J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s41231-019-0032-9
- URN
-
urn:nbn:de:101:1-2019031222434440983779
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Singh, Puneet
- Souza, Paul de
- Scott, Kieran F.
- Hall, Bruce M.
- Verma, Nirupama D.
- Becker, Therese M.
- Toh, James W. T.
- Sajinovic, Mila
- Spring, Kevin J.
- SpringerLink (Online service)
Other Objects (12)
PD1/PD-L1 immune checkpoint as a potential target for preventing brain tumor progression
Expression von PD1 und PD-L1 in entzündlichen Herzerkrankungen
Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy
Acquired resistance to anti-PD1 therapy: checkmate to checkpoint blockade?
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma
PD1/PD-L1 dependent immunosuppression by huiPS-derived cell population
Influence of CD38/PD1 co-expression on T cell subsets in HIV-TB co-infection
Alterations of circulating lymphocyte subsets in patients with colorectal carcinoma
Alterations of circulating lymphocyte subsets in patients with colorectal carcinoma
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy
Expression of PD1 and PDL1 as immune-checkpoint inhibitors in mantle cell lymphoma
Rituximab may affect T lymphocyte subsets balance in primary membranous nephropathy
PD1/PD-L1 immune checkpoint as a potential target for preventing brain tumor progression
Expression von PD1 und PD-L1 in entzündlichen Herzerkrankungen
Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy
Acquired resistance to anti-PD1 therapy: checkmate to checkpoint blockade?
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma
PD1/PD-L1 dependent immunosuppression by huiPS-derived cell population
Influence of CD38/PD1 co-expression on T cell subsets in HIV-TB co-infection
Alterations of circulating lymphocyte subsets in patients with colorectal carcinoma
Alterations of circulating lymphocyte subsets in patients with colorectal carcinoma
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy
Expression of PD1 and PDL1 as immune-checkpoint inhibitors in mantle cell lymphoma
Rituximab may affect T lymphocyte subsets balance in primary membranous nephropathy
PD1/PD-L1 immune checkpoint as a potential target for preventing brain tumor progression
Expression von PD1 und PD-L1 in entzündlichen Herzerkrankungen
Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy
Acquired resistance to anti-PD1 therapy: checkmate to checkpoint blockade?
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma
PD1/PD-L1 dependent immunosuppression by huiPS-derived cell population
Influence of CD38/PD1 co-expression on T cell subsets in HIV-TB co-infection
Alterations of circulating lymphocyte subsets in patients with colorectal carcinoma
Alterations of circulating lymphocyte subsets in patients with colorectal carcinoma
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy
Expression of PD1 and PDL1 as immune-checkpoint inhibitors in mantle cell lymphoma